Halil Bahcecioglu
Overview
Explore the profile of Halil Bahcecioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eldem B, Muftuoglu G, Topbas S, Cakir M, Kadayifcilar S, Ozmert E, et al.
Acta Ophthalmol
. 2014 Aug;
93(6):e458-64.
PMID: 25160859
Purpose: To compare visual outcomes, number of visits and ranibizumab injections in patients treated with a Wait & Extend (W&E) or Treat & Observe (T&O) regimen. Methods: This 12-month, randomized,...
2.
Tozun N, Sezgin O, Gulsen M, Kacar S, Yenice N, Yilmaz S, et al.
Turk J Gastroenterol
. 2012 Nov;
23(5):552-9.
PMID: 23161301
Background/aims: Pegylated alfa interferon is the only immunomodulatory drug licensed for hepatitis B. We evaluated the safety and tolerability of peginterferon alfa-2a (40KD) in patients with chronic hepatitis B. Materials...
3.
Artunay O, Senel A, Sengul A, Rasier R, Bahcecioglu H
Ocul Immunol Inflamm
. 2011 Nov;
19(6):453-5.
PMID: 22106918
Purpose: To report a case of central serous chorioretinopathy (CSC) as a possible complication of latanoprost treatment. Methods: A 65-year-old woman presented with a 1-week history of blurred vision and...
4.
Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H
BMJ Case Rep
. 2011 Jun;
2009.
PMID: 21687010
Retinal artery occlusions are usually the result of emboli, although non-embolic causes such as vasculitides, coagulopathies, and vasospasms resulting from migraines and inflammatory conditions do occur. Bevacizumab, a humanised monoclonal...
5.
Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Senel A, Bahcecioglu H
Retina
. 2011 Mar;
31(7):1279-86.
PMID: 21394063
Background: To evaluate combination treatment with intravitreal ranibizumab injection and reduced fluence photodynamic therapy for choroidal neovascularization associated with angioid streaks. Methods: This is an interventional case series of 10...
6.
Artunay O, Yuzbasioglu E, Unal M, Rasier R, Sengul A, Bahcecioglu H
J Ocul Pharmacol Ther
. 2010 Sep;
26(5):513-7.
PMID: 20874499
Purpose: The aim of this study was to compare the efficacy of bimatoprost 0.03% with brimonidine 0.2% in preventing intraocular pressure (IOP) elevations after neodymium:yttrium–aluminum–garnet (Nd:YAG) laser posterior capsulotomy. Methods:...
7.
Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H
J Ocul Pharmacol Ther
. 2010 Jun;
26(3):301-3.
PMID: 20565319
The posterior reversible encephalopathy syndrome (PRES), a complex of cerebral disorders including headache, seizures, visual disturbances, is associated with a variety of conditions in which blood pressure rises acutely. Arterial...
8.
Rasier R, Ozeren M, Artunay O, Bahcecioglu H, Seckin I, Kalaycoglu H, et al.
Cornea
. 2010 Jun;
29(9):985-90.
PMID: 20539215
Purpose: The aim of this study was to investigate the potential of infrared lasers for corneal welding to seal corneal cuts done in an experimental animal model. Materials And Methods:...
9.
Rasier R, Gormus U, Artunay O, Yuzbasioglu E, Oncel M, Bahcecioglu H
Curr Eye Res
. 2010 May;
35(6):505-9.
PMID: 20465445
Purpose: To determine intravitreal levels of interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha), and vascular endothelial growth factor (VEGF) in patients with rhegmatogenous retinal detachment (RD). Methods: Vitreous samples were collected...
10.
Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H
Curr Eye Res
. 2010 Feb;
35(2):91-8.
PMID: 20136418
Purpose: To evaluate and determine the effect of intravitreal bevacizumab in treatment of persistent central serous chorioretinopathy. Methods: This prospective, comparative clinical study included 30 eyes of 30 patients with...